4-硝基-α-甲苯磺酰氯 | 4025-75-6

• 物质功能分类: 化学试剂 - 有机试剂 - 酰卤
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-硝基-α-甲苯磺酰氯
• 中文别名: 1-(4-硝基苄基磺酰基)氯；4-硝基-Alpha-甲苯磺酰氯；对硝基苯甲磺酰氯；4-硝基-a-甲苯磺酰氯；(4-硝基苯基)甲磺酰氯
• 英文名称: (4-nitrophenyl)methanesulfonyl chloride
• 英文别名: p-nitrobenzylsulfonyl chloride；p-nitrophenylmethanesulfonyl chloride；4-nitrobenzylsulfonyl chloride；4-nitrobenzenemethanesulphonyl chloride
• CAS: 4025-75-6
• 化学式: C₇H₆ClNO₄S
• mdl: MFCD00034030
• 分子量: 235.648
• InChiKey: CAXRPEAFHWDFTD-UHFFFAOYSA-N

物化性质

• 熔点：
  91-92°C
• 沸点：
  396.4±25.0 °C(Predicted)
• 密度：
  1.570±0.06 g/cm3(Predicted)
• 稳定性/保质期：
  在常温常压下保持稳定

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  88.3
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险等级：
  8
• 安全说明：
  S22,S26,S30,S36/37/39,S45
• 危险品运输编号：
  UN3261
• 海关编码：
  2904909090
• 危险类别：
  8
• 危险品标志：
  C
• 危险类别码：
  R14,R34,R29
• 包装等级：
  II
• WGK Germany：
  3
• 危险性防范说明：
  P280,P305+P351+P338,P310
• 危险性描述：
  H314
• 储存条件：
  请将药品存放在避光、通风干燥的环境中，并密封保存。

SDS

Name:	(4-Nitrophenyl)methanesulfonyl chloride Material Safety Data Sheet
Synonym:	None Known
CAS:	4025-75-6

Section 1 - Chemical Product MSDS Name:(4-Nitrophenyl)methanesulfonyl chloride Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
4025-75-6	(4-Nitrophenyl)methanesulfonyl chlorid	95+	unlisted

Hazard Symbols: C
Risk Phrases: 14 34

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Reacts violently with water. Causes burns.Water-reactive.
Potential Health Effects
Eye:
Causes eye burns.
Skin:
Causes skin burns.
Ingestion:
Causes gastrointestinal tract burns.
Inhalation:
Causes chemical burns to the respiratory tract.
Chronic:
Chronic exposure may cause effects similar to those of acute exposure.

---

Section 4 - FIRST AID MEASURES
Eyes: In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Get medical aid immediately.
Skin:
If water-reactive products are embedded in the skin, no water should be applied. The embedded products should be covered with a light oil. In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Get medical aid immediately. Wash clothing before reuse.
Ingestion:
If swallowed, do NOT induce vomiting. Get medical aid immediately.
If victim is fully conscious, give a cupful of water. Never give anything by mouth to an unconscious person.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Water Reactive. Material will react with water and may release a flammable and/or toxic gas.
Extinguishing Media:
Use dry sand or earth to smother fire. DO NOT USE WATER! Do NOT get water inside containers. Contact professional fire-fighters immediately.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation. Do not expose spill to water.

---

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Keep container tightly closed. Do not ingest or inhale. Do not allow contact with water. Discard contaminated shoes.
Keep from contact with moist air and steam. Use only with adequate ventilation.
Storage:
Keep container closed when not in use. Keep away from water. Store protected from moisture. Store under an inert atmosphere.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use explosion-proof ventilation equipment. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 4025-75-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use. Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Powder
Color: white
Odor: slight
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 90-93 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H6ClNO4S
Molecular Weight: 235.649

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Combines vigorously or explosively with water. Reacts with water to form hydrogen chloride, a toxic and corrosive gas.
Conditions to Avoid:
Dust generation, moisture, exposure to moist air or water.
Incompatibilities with Other Materials:
Oxidizing agents, bases, amines, water.
Hazardous Decomposition Products:
Hydrogen chloride, carbon monoxide, oxides of nitrogen, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 4025-75-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
(4-Nitrophenyl)methanesulfonyl chloride - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION
Ecotoxicity:
Fish: Pseudomonas putida:

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: CORROSIVE SOLID, WATER-REACTIVE, N.O.S.
Hazard Class: 8
UN Number: 3096
Packing Group: II
IMO
Shipping Name: CORROSIVE SOLID, WATER-REACTIVE, N.O.S.
Hazard Class: 8
UN Number: 3096
Packing Group: II
RID/ADR
Shipping Name: CORROSIVE SOLID, WATER-REACTIVE, N.O.S.
Hazard Class: 8
UN Number: 3096
Packing group: II

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 14 Reacts violently with water.
R 34 Causes burns.
Safety Phrases:
S 6 Keep under nitrogen.
S 22 Do not breathe dust.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 4025-75-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 4025-75-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 4025-75-6 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-硝基-α-甲苯磺酰氯 在 三乙胺 作用下， 以 乙腈 为溶剂， 生成 trans-4,4'-dinitrostilbene
  参考文献：
  名称：

  对称烯烃überepisulfone ausprimären磺酰氯

  摘要：

  伯磺酰氯RCH 2 SO 2 Cl（R = Alk或Ar）在乙腈溶液中于-40°C与三乙胺反应，制得顺式和反式-2,3-二取代的噻喃-1,1-二氧化物的混合物，可以是热解为相应的Z和E烯烃。

  DOI：

  10.1016/s0040-4039(00)99182-2
• 作为产物：
  描述：

  4-硝基硫氰酸苄酯 在 水 、 氯 作用下， 生成 4-硝基-α-甲苯磺酰氯
  参考文献：
  名称：

  Process of producing sulphonyl halides

  摘要：

  公开号：

  US02174856A1

文献信息

• Clean and Economic Synthesis of Alkanesulfonyl Chlorides from S-Alkyl Isothiourea Salts via Bleach Oxidative Chlorosulfonation
  作者：Jiaxi Xu、Zhanhui Yang、Bingnan Zhou

  DOI：10.1055/s-0033-1338567

  日期：——

  Abstract A simple procedure for clean and economic synthesis of alkanesulfonyl chlorides via bleach-mediated oxidative chlorosulfonation of S-alkyl isothiourea salts is disclosed. This procedure is environment- and worker-friendly with the advantages of readily accessible materials and reagents, simple and safe operations, easy purification without chromatography, and affords high yields of up to 99%

  摘要 公开了通过漂白介导的S-烷基异硫脲盐的氧化氯磺化来清洁和经济地合成烷烃磺酰氯的简单方法。该方法对环境和工人均有利，具有易于获得的材料和试剂，简单安全的操作，无需色谱法即可轻松纯化的优点，并提供高达99％的高收率。 公开了通过漂白介导的S-烷基异硫脲盐的氧化氯磺化来清洁和经济地合成烷烃磺酰氯的简单方法。该方法对环境和工人均有利，具有易于获得的材料和试剂，简单安全的操作，无需色谱法即可轻松纯化的优点，并提供高达99％的高收率。
• Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer
  作者：Yan Zhang、Xishan Wu、Xiaoqian Xue、Chenchang Li、Junjian Wang、Rui Wang、Cheng Zhang、Chao Wang、Yudan Shi、Lingjiao Zou、Qiu Li、Zenghong Huang、Xiaojuan Hao、Kerry Loomes、Donghai Wu、Hong-Wu Chen、Jinxin Xu、Yong Xu

  DOI：10.1021/acs.jmedchem.9b00327

  日期：2019.5.9

  complex with the RORγ ligand binding domain provided a solid structural basis for its antagonistic mechanism. 27 potently inhibited cell growth, colony formation, and the expression of AR, AR-V7, and PSA. 27 also exhibited good metabolic stability and a pharmacokinetic profile with oral bioavailability of 59% and a half-life of 7.3 h. Notably, 27 demonstrated promising therapeutic effects with significant

  我们报告了核受体RORγ反向激动剂作为前列腺癌治疗药物的设计，优化和生物学评估。最有效的化合物27（指定为XY101）在基于细胞的报告基因分析中表现出细胞活性，IC50值为30 nM，对其他核受体亚型具有良好的选择性。27与RORγ配体结合域复合的共晶体结构为其拮抗机制提供了坚实的结构基础。27有效抑制细胞生长，集落形成以及AR，AR-V7和PSA的表达。27还表现出良好的代谢稳定性和药代动力学特征，口服生物利用度为59％，半衰期为7.3小时。尤其，图27显示了在小鼠的前列腺癌异种移植模型中具有显着的肿瘤生长抑制作用的有希望的治疗作用。有效的，选择性的，代谢稳定的和口服可用的RORγ反向激动剂代表了一类新型化合物，可作为对抗前列腺癌的潜在疗法。
• Orally active, nonpeptide oxytocin antagonists
  作者：Ben E. Evans、James L. Leighton、Kenneth E. Rittle、Kevin F. Gilbert、George F. Lundell、Norman P. Gould、Doug W. Hobbs、Robert M. DiPardo、Daniel F. Veber、Douglas J. Pettibone、Bradley V. Clineschmidt、Paul S. Anderson、Roger M. Freidinger

  DOI：10.1021/jm00099a020

  日期：1992.10

  The first nonpeptide antagonists of the neurohypophyseal hormone, oxytocin (OT) are described. Derivatives of the spiroindenepiperidine ring system, these compounds include L-366,509, an orally bioavailable OT antagonist with good in vivo duration. The potential use of these agents for treatment of preterm labor and their significance as new nonpeptide ligands for peptide receptors are discussed.

  描述了神经下垂体激素催产素（OT）的第一个非肽拮抗剂。这些化合物是螺茚并哌啶环系统的衍生物，包括L-366509，这是一种口服生物可利用的OT拮抗剂，在体内具有良好的持续时间。讨论了这些药物在治疗早产中的潜在用途及其作为肽受体新的非肽配体的重要性。
• Discovery and Characterization of Benzimidazole Derivative XY123 as a Potent, Selective, and Orally Available RORγ Inverse Agonist
  作者：Xishan Wu、Hui Shen、Yan Zhang、Chao Wang、Qiu Li、Cheng Zhang、Xiaoxi Zhuang、Chenchang Li、Yudan Shi、Yanli Xing、Qiuping Xiang、Jinxin Xu、Donghai Wu、Jinsong Liu、Yong Xu

  DOI：10.1021/acs.jmedchem.1c00763

  日期：2021.6.24

  (IC50) value of 64 nM and showed excellent selectivity against other nuclear receptors. 27h also potently suppressed cell proliferation, colony formation, and the expression of androgen receptor (AR)-regulated genes in AR-positive prostate cancer cell lines. In addition, 27h demonstrated good metabolic stability and a pharmacokinetic property with reasonable oral bioavailability (32.41%) and moderate half-life

  受体相关孤儿受体γ（RORγ）已成为治疗癌症和炎症性疾病的一个有吸引力的治疗靶点。在此，我们报告了我们在苯并噻唑和苯并咪唑衍生物作为 RORγ 新型反向激动剂的发现、优化和评估方面所做的努力。代表性化合物27h （命名为XY123）有效抑制RORγ转录活性，半数抑制浓度（IC 50 ）值为64 nM，并对其他核受体表现出优异的选择性。 27h还有效抑制 AR 阳性前列腺癌细胞系中的细胞增殖、集落形成和雄激素受体 (AR) 调节基因的表达。此外， 27h表现出良好的代谢稳定性和药代动力学特性，具有合理的口服生物利用度 (32.41%) 和中等的半衰期 ( t 1/2 = 4.98 h)。值得注意的是，口服化合物27h在小鼠22Rv1异种移植肿瘤模型中实现了完全且持久的肿瘤消退。化合物27h可能作为一种新的有价值的先导化合物，用于进一步开发治疗前列腺癌的药物。
• [EN] STRAD-BINDING AGENTS AND USES THEREOF<br/>[FR] AGENTS DE LIAISON À STRAD ET LEURS UTILISATIONS
  申请人：UNIV CALIFORNIA

  公开号：WO2021155004A1

  公开（公告）日：2021-08-05

  Disclosed herein, inter alia, are compounds for binding STRAD pseudokinase and uses thereof.

  披露的内容包括，但不限于，用于结合STRAD假激酶的化合物及其用途。